Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Japanese functional protein production company seeks Chinese partners.
|Total value of the target||N/A|
|Expected target net rate of return after deducting all taxes and fees||N/A|
|Validity period of pending order||365|
Senior Associate, International Business Advisory
|Project highlights||genome editing tech - A-round USD 6.2 million - B-Round USD 10 m target|
The Japanese company uses genome editing technology to extract functional proteins from farmed chickens and provide them as pharmaceutical raw materials to antibody, vaccine and other pharmaceutical companies. The CTO and CSO are the active professor and associate professor of the University of Tokushima respectively. The company completed A-round financing of USD 6.2 million in 2020 and plans to launch B-round financing of USD 10 million in the near future. It hopes to establish cooperative relations with relevant Chinese enterprises and obtain Chinese investment.
Enquire for more information about our services, and how we can help solve challenges for your organizationContact Us